NEWSROOM
DrFalk_Website_Header_2400x900_Generisch1

Le ultime notizie da
Dr. Falk Pharma

Benvenuti nella nostra Newsroom, che vi fornirà le ultime notizie, comunicati stampa, annunci di studi clinici, eventi, e altro ancora dal
Dr. Falk Pharma.

Seguici anche su LinkedIn!

Corporate

Conferenza Stampa a Milano

01.12.2022

Lancio della Dr. Falk Pharma Italia

Più

Corporate, Comunicati stampa

Collaboration and Licensing Agreement with Takeda and Zedira

20.10.2022

To Develop First-in-Class Celiac Disease Therapy

Più

Logo UEG Week
Evento

UEG Week 2022

19.09.2022

Join us from October 8 – 11 in Vienna on booth no. 43 or virtually!

Più

Logo Zedira
Corporate, Comunicati stampa, Studi

NAFLD: Phase 2a proof of concept study of ZED1227

01.07.2022

Dr. Falk Pharma and Zedira announce trial start for the treatment of non-alcoholic fatty liver disease. First patient enrolled in April.

Più

Comunicati stampa, Indicazioni

Have difficulty swallowing food?

10.05.2022

Difficulty swallowing and pain while eating may be warning signs of eosinophilic esophagitis (EoE). The first EoE Day will be held on May 22, 2022.

Più

Corporate

Response to the Ukraine crisis

18.03.2022

Dr. Falk Pharma supports APOTHEKER HELFEN e.V.

Più

Corporate, Comunicati stampa

Future starts here

24.02.2022

Plans for the future Falk Campus in Freiburg-Nord finalized.

Più